Ginkgo Bioworks Holdings (DNABW) Profit After Tax (2020 - 2026)

Ginkgo Bioworks Holdings (DNABW) reported Profit After Tax of -$76.1 million for Q1 2026, up 16.38% on a YoY basis from -$65.4 million in Q1 2025, and up 5.81% quarter-over-quarter from -$80.8 million in Q4 2025.

Ginkgo Bioworks Holdings (DNABW) Profit After Tax (2020 - 2026) Analysis & Trends

Ginkgo Bioworks Holdings has reported Profit After Tax for 7 years, with the latest figure at -$76.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Profit After Tax rose 16.38% year-over-year to -$76.1 million; the trailing twelve-month figure through Mar 2026 stood at -$297.9 million (up 36.9% YoY), and the FY2025 full-year result was -$312.8 million, up 42.83% from the prior year.
  • Profit After Tax for Q1 2026 stood at -$76.1 million, up from -$80.8 million in the prior quarter.
  • The five-year high for Profit After Tax was -$56.4 million in Q3 2024, with the low at -$670.6 million in Q2 2022.
  • Historically, Profit After Tax has averaged -$231.6 million across 5 years, with a median of -$173.3 million in 2023.
  • The largest YoY upside for Profit After Tax was 89.04% in 2022 against a maximum downside of 1131.22% in 2022.
  • Ginkgo Bioworks Holdings' Profit After Tax stood at -$175.5 million in 2022, then slipped by 20.65% to -$211.7 million in 2023, then surged by 49.2% to -$107.5 million in 2024, then gained by 24.91% to -$80.8 million in 2025, then climbed by 5.81% to -$76.1 million in 2026.
  • The last three Profit After Tax figures came in at -$76.1 million (Q1 2026), -$80.8 million (Q4 2025), and -$80.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.90 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.63 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -753,254.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.74 Mn
10 Ginkgo Bioworks Holdings - - 16.38 Mn -76.06 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -76.06 Mn
Dec 31, 2025 -80.75 Mn
Sep 30, 2025 -80.76 Mn
Jun 30, 2025 -60.30 Mn
Mar 31, 2025 -90.96 Mn
Dec 31, 2024 -107.53 Mn
Sep 30, 2024 -56.40 Mn
Jun 30, 2024 -217.18 Mn
Mar 31, 2024 -165.91 Mn
Dec 31, 2023 -211.69 Mn
Sep 30, 2023 -302.89 Mn
Jun 30, 2023 -173.32 Mn
Mar 31, 2023 -204.97 Mn
Dec 31, 2022 -175.47 Mn
Sep 30, 2022 -670.13 Mn
Jun 30, 2022 -670.57 Mn
Mar 31, 2022 -592.59 Mn
Dec 31, 2021 -1.60 Bn
Sep 30, 2021 -102.41 Mn
Jun 30, 2021 -54.46 Mn